Biopharmaceutical Association (CBA), USA
Biopharmaceutical Association-USA (CBA) (www.cba-usa.org) is one of the largest
Chinese American professional associations in the US. Founded in 1995 by a
group of Chinese-American biopharmaceutical professionals, CBA is an independent,
non-political, and not-for-profit professional organization headquartered in
the Washington DC area. The membership
now comprises more than 3,000 biopharmaceutical related professionals from industry, academia, and
government. Over 80 percent of the members hold Ph.D., M.D. and/or J.D.
degrees. CBA also has over one hundred Institutional Members.
The mission of
CBA is to promote communication and collaboration among biopharmaceutical
professionals and to promote technology transfer and business collaborations
among different countries and regions, especially between the United States,
China, and other countries in the Pacific Rim.
year, CBA organizes and co-organizes a number of specially designed workshops,
seminars, meetings, and networking gatherings to meet its members’ career
advancement needs. As CBA’s most influential event,
CBA’s annual conference attracts hundreds of attendees each year including many
internationally renowned research scientists, business leaders, and
high-ranking US and Chinese government officials. CBA has co-organized the annual Shanghai
Bioforum with the Shanghai Municipal Government Commission of Science and Technology
in 2008, the 1st Pearl River International Biopharmaceutical Forum held in
Guangdong in 2009 and the 17th Annual CBA Conference in
Qingdao in 2012.
undertaken many activities to strengthen relationships between China and the US
and promote the Chinese biotechnology industry, holding seminars, conferences,
and forums in major cities in China. CBA has an excellent reputation both in
China and the U.S. for developing and enhancing friendship and cooperation
within the biopharmaceutical and life sciences industries. Our efforts have been
applauded by industry executives and prominent leaders from both US and China.
The past Minister of Health of China, Dr. Chen Zhu, former US Deputy Secretary
of Labor Sam Mok, former Chinese Ambassadors to US Wenzhong Zhou and Daoyu Li,
and dozens of prominent leaders from academia, industry and government have
attended and addressed CBA annual conferences.
Over the years, CBA has gained a great reputation in both
China, US, as well as other parts of the world. As one of the most recognized Chinese American professional
organizations in the US, CBA’s activities are popular among professionals with
different cultural backgrounds. A number of prestigious scientific magazines,
including Nature, Science, and Bioprocess International, have reported CBA, its event, as well as
celebrated its 20th Anniversary in its New Year Gala in February 2015 and 20th annual conference in Chao Hu and Lian
Yun Gang at the end of June 2015. The success of the
organization can be attributed to the active involvement of members around the
US who believe in its mission. Today, the global biopharmaceutical industry and
healthcare continue to evolve and grow, particularly in China and the Asia
Pacific area, and CBA members look up to
participate in the challenges ahead.